Limit Quinolones Due to Aortic Aneurysm and Rupture Risks

Rupture of aortic aneurysm is the latest quinolone risk...leading FDA to require added warnings on oral and injectable quinolone labels.

Aortic aneurysm and rupture are rare...and may occur in about one in every 11,000 patients overall each year. But they can be fatal.

That number can jump to one in about 300 high-risk patients. This includes the elderly...patients with a history of aneurysm, hypertension, vascular disease, or smoking...or those with some genetic conditions.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote